Lang Brian Hung-Hin, Lo Chung-Yau, Chan Wai-Fan, Lam Alfred King-Yin, Wan Koon-Yat
Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China.
World J Surg. 2006 May;30(5):752-8. doi: 10.1007/s00268-005-0356-7.
The follicular variant of papillary thyroid carcinoma (FVPTC) is the most common histologic subtype of papillary thyroid carcinoma (PTC). However, it is still controversial whether FVPTC should behave differently from classical PTC (CPTC). The present study aimed at evaluating any potential difference in clinicopathologic features and long-term outcome of FVPTC as compared with CPTC.
Of 568 patients with PTC managed from 1973 to 2004, 308 were shown to have CPTC (54.2%) and 67 (11.8%) FVPTC after histologic review. The mean (+/- SD) follow-up period was 11.3 (+/- 8.9) years. The two groups were compared in terms of clinicopathological features, treatment received, and outcome regarding recurrence and disease-specific survival.
There was no difference in age and gender ratio between the CPTC and FVPTC patients. Both groups had similar tumor characteristics in terms of tumor size, presence of multifocality, capsular invasion, lymphovascular permeation, and perineural infiltration. However, FVPTC patients had significantly fewer histologically confirmed cervical lymph node metastases (P = 0.027) and extrathyroidal involvement (P = 0.005). The proportion of bilateral resection, adjuvant radioactive iodine, and lymph node dissection did not differ significantly between the two groups. The FVPTC patients had a more favorable tumor risk by DeGroot classification (P = 0.003) and MACIS (Metastasis, Age, Completeness of excision, Invasiveness, and Size) score (P = 0.026). The 10- and 15-year actuarial disease-specific survivals did not differ significantly between FVPTC and CPTC patients (96.2% versus 90.7% and 96.2% versus 89.1%, respectively).
Although patients with FVPTC had more favorable clinicopathologic features and a better tumor risk group profile, their long-term outcome was similar to that of CPTC patients.
甲状腺乳头状癌滤泡亚型(FVPTC)是甲状腺乳头状癌(PTC)最常见的组织学亚型。然而,FVPTC的行为是否与经典PTC(CPTC)不同仍存在争议。本研究旨在评估FVPTC与CPTC相比在临床病理特征和长期预后方面的任何潜在差异。
在1973年至2004年接受治疗的568例PTC患者中,经组织学复查,308例为CPTC(54.2%),67例为FVPTC(11.8%)。平均(±标准差)随访期为11.3(±8.9)年。比较两组的临床病理特征、接受的治疗以及复发和疾病特异性生存的结局。
CPTC和FVPTC患者在年龄和性别比例上无差异。两组在肿瘤大小、多灶性、包膜侵犯、淋巴管浸润和神经周围浸润方面具有相似的肿瘤特征。然而,FVPTC患者经组织学证实的颈部淋巴结转移(P = 0.027)和甲状腺外侵犯(P = 0.005)明显较少。两组之间双侧切除、辅助放射性碘治疗和淋巴结清扫的比例无显著差异。根据DeGroot分类(P = 0.003)和MACIS(转移、年龄、切除完整性、侵袭性和大小)评分(P = 0.026),FVPTC患者的肿瘤风险更有利。FVPTC和CPTC患者的10年和15年精算疾病特异性生存率无显著差异(分别为96.2%对90.7%和96.2%对89.1%)。
尽管FVPTC患者具有更有利的临床病理特征和更好的肿瘤风险组特征,但其长期预后与CPTC患者相似。